Harmony Biosciences Holdings, Inc. Common Stock Profile
About
Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.
Info & Links
CEO
Jeffrey M. Dayno
Headquarters
630 W. Germantown Pike, Suite 215 Plymouth Meeting, PA 19462, UNITED STATES
Harmony Biosciences Holdings, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
1.63B
Enterprise Value
1.36B
Enterprise Value/EBITDA(ttm)
6.38
Price to Earnings Ratio(ttm)
16.54
Price to Sales(ttm)
2.92
Price to Book(mrq)
3.33
Price to Cash(ytd)
13.38
Profitability
Gross Margin(ttm)
78.40%
Operating Margin(ttm)
17.98%
Profit Margin(ttm)
20.21%
Return on Equity(ttm)
23.16%
Return on Invested Capital(ttm)
19.23%
Return on Assets(ttm)
14.24%
Income Statement
Revenue(ttm)
714.73M
Revenue Per Share(ttm)
12.46
Gross Profit(ttm)
557.92M
EBITDA(ttm)3
213.38M
Net Income Available to Common(ttm)
145.49M
Diluted EPS(ttm)
2.11
Share Statistics
Beta (5Y Monthly)
0.80
52-Week Change
-2.45%
S&P 500 52-Week Change
6.35%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
57.35M
Dividend Yield
0.00%
Float4
39.47M
% Held by Insiders
30.80%
% Held by Institutions
86.23%
Balance Sheet
Total Cash(mrq)
467.19M
Total Cash Per Share(mrq)
8.15
Total Debt(mrq)
179.27M
Total Debt/Equity(mrq)
27.20%
Current Ratio(mrq)
3.31%
Quick Ratio(mrq)
3.20%
Book Value Per Share(mrq)
11.53
Cash Flow
Operating Cash Flow Per Share(ytd)
3.80
Free Cash Flow(ytd)
218.67M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.